Industry News
All Scott Whitaker News
Top stories summarized by our editors
Top stories summarized by our editors

Biden administration to spend $1.6B to boost COVID-19 testing

2/22/2021

The Biden administration will be providing $1.6 billion to expand COVID-19 testing, improve virus genome sequencing to detect variants of the virus and boost domestic manufacturing of tests and testing supplies. "We commend President Biden and the administration for their commitment to expanding federal investment in COVID-19 testing supplies," said AdvaMed CEO and President Scott Whitaker.

Biden administration to spend $1.6B to boost COVID-19 testing

2/18/2021

The Biden administration will be providing $1.6 billion to expand COVID-19 testing, improve virus genome sequencing to detect variants of the virus and boost domestic manufacturing of tests and testing supplies. "We commend President Biden and the administration for their commitment to expanding federal investment in COVID-19 testing supplies," said AdvaMed CEO and President Scott Whitaker.

Medtech industry congratulates Biden, Harris

1/22/2021

AdvaMed and other medical device industry groups have congratulated and offered their support to President Joe Biden and Vice President Kamala Harris. "At AdvaMed, our top priority is delivering next-generation innovation to save and improve lives, and we are encouraged to by your readiness to improve patient access and patient outcomes. We stand ready to work with you and your teams to ensure that all Americans can continue to receive the very best health care in the world," said AdvaMed CEO and President Scott Whitaker.

Medtech industry condemns D.C. violence

1/8/2021

AdvaMed, along with other industry groups, has condemned the violence that occurred at the Capitol in Washington, D.C. last Tuesday. "Today's violence at the U.S. Capitol does not represent who we are or who we should be as a nation," said AdvaMed President and CEO Scott Whitaker, adding, "In this country, we settle our political differences by passionately but peacefully seeking changes in policy through the process established by our Constitution."

Millions of COVID-19 tests to be produced by month's end

12/16/2020

By the end of March, diagnostics companies with emergency use authorizations plan to produce millions of COVID-19 tests weekly by the end of this month. "Many companies are adding third shifts, working 24/7, and adding new production lines in order to provide patients and health care providers what they need to detect, contain and treat this virus," said AdvaMed President and CEO Scott Whitaker.

Shipments of COVID-19 tests in US surpass 150M

9/18/2020

According to the latest data from the AdvaMed COVID-19 testing supply registry, more than 150 million COVID-19 molecular diagnostic tests have been shipped out in the US. "We anticipate test manufacturers will ship between 32 and 35 million molecular tests in September. Add to that the more than 100 million antigen tests expected to be shipped by the end of fall, and it's clear our industry is committed to meeting the demands of the COVID-19 crisis," said AdvaMed President and CEO Scott Whitaker.

Medtech industry touts COVID-19 supply registry

8/4/2020

The AdvaMed COVID Testing Supply Registry will be an important resource for state and federal authorities as they work to protect public health and support patient care, notes AdvaMed CEO and President Scott Whitaker. "It is absolutely vital to our nation's health and economic recovery that we are capable of testing everyone who needs it, and, just as important, that we know manufacturers will continue their massive mobilization effort to send testing supplies where they are most needed," he writes.

1M COVID-19 tests shipped per day

8/3/2020

According to AdvaMed's national testing registry, shipments of COVID-19 tests within the US reached 1 million per day for the week that ended July 24. "Widespread and widely available testing is key to our ability as a nation to overcome this public health crisis, and our industry is committed to providing the testing supplies and information health care providers need in order to achieve the necessary testing capacity," said AdvaMed President and CEO Scott Whitaker.